PKI-402

PKI-402 is a selective, reversible, ATP-competitive, class I inhibitor of phosphatidylinositol 3-kinase (PI3K). PKI-402 inhibits the growth of human tumor cell lines derived from breast, brain, pancreatic and non-small cell lung cancer tissue.
Supplier Alfa Cytology
Product # BC0189
Pricing 5.0 mg, 10.0 mg, inquire
Feedback